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Abstract 
 
Background: To assess the effect of concomitant subgingival rinsing with 10% PVP-iodine during 
subgingival instrumentation on the prevalence and magnitude of bacteremia of oral origin.  
Materials and Methods: Subgingival instrumentation was performed with water or PVP-iodine rinse 
in patients with periodontitis. Prior to instrumentation, subjects gargled for 1 min with the allocated 
liquid. Pockets were then rinsed for 1 min and subgingivally instrumented with liquid-cooled 
(water/PVP-iodine) ultrasonic scalers (1 min). Two minutes later, a blood sample from the arm vein 
was drawn using a lysis centrifugation blood culture system for quantitative microbiological analysis. 
Non-parametric statistical tests were performed to assess differences in the prevalence and extent of 
bacteremia between groups.  
Results: Of the 19 samples in each group, oral-borne bacteremia was detected in 10 of the control 
and 2 of the test samples. With an average of 3.0 [1;5] colony forming units, significantly less bacteria 
and bacteremia were found in the test group compared to the controls (12.2 [1;46]) (p=0.003). 
Anaerobic bacteria were not found in the test group. 
Conclusions: Bacteremia after subgingival instrumentation with concomitant PCP-iodine rinsing is 
reduced but not eliminated. Therefore, it might be recommended for patients at a high risk of 
endocarditis or infection of endoprostheses. However, preventive antibiotic treatment should not be 
omitted.  
Clinical Relevance:  
Scientific Rationale for Study: Before undergoing dental treatment, patients at a high risk for 
endocarditis or inflammation of endoprosthesis are encouraged to take prophylactic antibiotics to kill 
vital bacteria that have entered the bloodstream. However, antibiotics do not hinder vial bacteria’s 
passage into the host organism. Intensive rinsing with PVP-iodine before and during biofilm disruption 
might be an alternative approach to lower the risk of bacteremia.  
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Principal Findings: Rinsing with PVP-iodine before and during subgingival instrumentation 
significantly lowers the risk for post-treatment bacteremia and the number of CFU in cases of 
bacteremia and seems to prevent bacteremia, especially from anaerobic strains.  
Practical Implications: Patients with a limited health status might benefit from the described rinsing 
regime. 
 
 
 
Introduction 
 
Periodontitis is a common inflammatory disease (Albandar & Rams 2002, Loe 1983, 
Oliver et al.  1998) characterized by a progressive loss of the tooth-supporting hard and soft 
tissues (Flemmig 1999). The primary cause for this pathologic condition is biofilms that colonize 
and subsequently mature on the affected root surfaces (Sanz & van Winkelhoff 2011). The 
bacterial composition is characterized by a high proportion of Gram-negative anaerobes (Komiya 
Ito et al.  2010, Socransky et al.  1998, van Winkelhoff et al.  2002). Located in 
direct proximity to well-perfused tissues such as gingiva and the periodontal ligament, these bacteria 
induce chronic inflammation by the host (Tatakis & Kumar 2005), which is triggered mainly by 
means of lipopolysaccharides. (Bascones et al.  2005).  
Theories regarding the effects of chronically inflamed periodontal wound surfaces on general health 
have long been considered. Ongoing research has provided strong evidence for the bidirectional 
association of diabetes mellitus and periodontitis, while recent studies on periodontitis and 
rheumatoid arthritis or cardiovascular diseases show growing evidence of a relationship beyond just 
an association (de Pablo et al.  2009, Kiran et al.  2005, Tonetti & Van Dyke 2013). 
The linkage is generally explained by a periodic contamination of the blood stream by bacteria and 
their metabolites derived from subgingival wounds. Both might enter the blood circulation in elevated 
concentrations during daily activities such as chewing and tooth-brushing. In addition, mechanical 
root debridement, as the essential component of initial periodontal therapy, may cause bacteremia. 
While a subsequent functional impairment of the endothelium’s physiological capability to regulate 
blood flow rate is a short effect (Tonetti et al.  2007), bacterial adherence and the proliferation of 
living bacteria on non-shedding surfaces of artificial endoprostheses, such as artificial joints or heart 
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valves, are still important subjects of ongoing discussion concerning their associated infective health 
risks (Zimmerli et al.  2004). Therefore, guidelines recommend the preventive systemic 
administration of antibiotics before dental treatment, especially for well-defined high-risk patients 
(Wilson et al.  2008). Despite the fact that some studies showed that the antibiotic approach 
might be highly potent in terms of bactericidal effects on circulating germs in the bloodstream 
(Denning et al.  1984), this medication does not actually provide a safe elimination of bacteria 
(Seo et al.  2014, Duvall et al.  2013)} or any obstacle for the transition of viable bacteria 
into the bloodstream.    
PVP-iodine is a cheap broad-spectrum antiseptic agent frequently used in the therapy of periodontitis, 
especially in Scandinavia (Rosling et al.  2001) and Switzerland (Sahrmann et al.  2014). 
Its spectrum of action covers bacteria associated with periodontitis (Reimer et al.  1998) and its 
use as a rinse during initial periodontal therapy has been proven to provide a significant therapeutic 
benefit in terms of pocket depth reduction (Sahrmann et al.  2014). Nevertheless, there is only 
weak data regarding its effect on the prevention of oral-borne bacteremia during initial periodontitis 
therapy.  Discordant results regarding bacteremia have been obtained from studies that performed 
instrumentation with ultrasonic devices or with hand instruments (Cherry et al.  2007, 
Witzenberger et al.  1982). Notably, none of these studies applied the antiseptic during 
subgingival instrumentation, when the disruption of the biofilms actually occurs. 
Therefore, it was the aim of the present study to assess the impact of PVP-iodine rinsing before 
ultrasonic root instrumentation and concomitantly with this instrumentation on the prevalence and the 
extent of oral-borne bacteremia in patients with chronic periodontitis.  
 
 
 
Materials & Methods 
 
Study design 
The present study was conducted as a single-center, randomized, placebo-controlled clinical study 
with a split-mouth cross-over design. The study protocol was approved by the liable Ethical 
Committee of Zurich, Switzerland (KEK-Zh-Nr. 2011-0076) and authorized by the responsible national 
authority for the observation of therapeutic products (Swissmedic, Berne, Switzerland, registration 
number 2012DR3047). The study was notified in the registry database of the U.S. National Institutes 
of Health (www.Clinicaltrials.com, identifier NCT01647347) and was conducted in accordance with 
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the guidelines of Good Clinical Practice and the revised Declaration of Helsinki for clinical studies 
(Morris 2013). The entire study process was monitored by an external facility (Clinical Trials 
Center, Zurich, Switzerland). As previously planned, clinical and office performance was scrutinized 
during five monitoring sessions during the entire study process.  
 
Study population 
While feasible data for a reasonable power analysis were missing, it was planned to conduct the 
study on 20 patients.  
The study was composed of male and female patients over 18 years of age with moderate or severe 
chronic periodontitis with at least 2 sites with PD ≥ 5 mm in each quadrant.  Patients with systemic 
diseases or medications known to interfere with periodontal therapy were not included. Furthermore, 
patients who underwent antibiotic therapy or anticoagulation therapy during the preceding 6 months, 
those on thyroid medication or with a known allergy to PVP-iodine were excluded from this study.  
Females who were pregnant or breastfeeding were also not included in this trial.  
Outpatients visiting the Clinic of Preventive Dentistry, Cariology and Periodontology of the University 
of Zurich for periodontal treatment were screened for possible inclusion (PhS).   
 
 
Clinical procedure 
 
A computer-randomized list was generated (AM) prior to the start of the study. Accordingly, groups 
indicating the treatment modalities (i.e., test or control treatment) and the treatment allocation (i.e., left 
or right half of the mouth) for the first appointment were prepared and placed into non-transparent 
envelopes. The envelopes were numbered from 1 to 20, according to the chronological order of the 
consecutively enrolled patients. The contents were concealed until immediately before the first 
treatment.  
After the first visit with the presentation of the study and the delivery of written patient information and 
the consent form, all questions regarding the study were addressed in a second meeting before 
patient agreement was finally received.  
 
Study treatment was performed as follows (see Figure 1): 
During the first appointment, the envelope with the group was opened and the allocation of the first 
course of instrumentation, i.e., left or right half of the mouth, and the solution to be applied was 
defined: PVP-iodine for the test or tap water for the control treatment.  
After local anesthesia was administered to areas with deep periodontal sites of the appropriate half of 
the oral cavity, the patient rinsed the mouth for exactly one minute with the corresponding test or 
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control liquid. Meanwhile, a tourniquet was loosely placed around the upper arm, and the bend of the 
elbow was disinfected twice with Kodan® (Schülke & Mayr AG, Zurich, Switzerland). Then, all 
periodontal sites in the area of interest were rinsed for another 60 sec with the same liquid using a 10 
ml single-use plastic syringe and a blunt tip with an inner diameter of 0.49 mm (Endo-EZE tip, 
Ultradent, UT South Jordan). Thereafter, these pockets were instrumented using an ultrasonic-driven 
device (CavitronPlus® and Slimline inserts, Dentsply deTrey, Graz, Austria) at the highest settings for 
power and lavage to churn up a maximum of subgingival biofilm for 60 seconds. During the study 
process, the ultrasonic device ran with the according liquids provided from the external cooling tank. 
Exactly 3 minutes after the start of the subgingival instrumentation, a blood sample of 10 ml was 
taken from the most visible arm vein after tightening the tourniquet. For the sampling, a combination 
of a Vacuette Viso Plus needle (Greiner Bio-One GmbH, Kremsmünster, Austria) and a vacuum 
isolator tube (Isolator 10, Oxoid AG, Pratteln, Switzerland) was used. Immediately after the sampling, 
the extraction site was compressed for at least 2 min. Finally, the sampling site was covered by an 
adhesive plaster. 
The second treatment was performed after a wash-out period of at least two weeks. The treatment 
was performed in line with the first treatment. However, in this case, the not yet allocated liquid was 
used in the remaining half of the mouth.  
Samples were labeled and stored in a dark place at room temperature until they were processed in 
the laboratory. 
Beyond the study protocol, proper periodontal therapy was provided in the according quadrants after 
performing the study at the same appointments.  
   
Microbiological analysis 
According to the study protocol, all samples were required to be processed within 8 hours after 
extraction. Due to the coding of the glass tubes, the microbiology staff was blinded regarding the 
treatment type of the corresponding blood samples.  
First, the samples were centrifuged at 3500 g for 10 min (Thermo Fisher Scientific, Heraeus 
LABOFUGE 400 Centrifuge, Hanau, Germany). Care was taken to allow an undisturbed coasting to 
standstill in order to not re-disperse the centrifugate.  Following a standardized method, the 
supernatant was removed with a pipette (Oxoid AG, Pratteln, Switzerland). After vortexing the 
remnants, three drops (app. 150 µl) were applied in each of the following culture media and 
dispensed with a wire loop: Columbia Agar + 5% sheep blood (COS, BioMérieux, Genève, 
Switzerland), Brucella agar (Becton Dickinson, Allschwil, Switzerland), Chocolat PolyViteX agar (PVX, 
BioMérieux), Mac Conkey agar (MCK, BioMérieux), Columbia CNA agar + 5% sheep blood (CNA, 
BioMérieux). The remaining material was placed into thioglycolate growing medium (Becton 
Dickinson).  
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The growing media were cultured under aerobic (MCK) and anaerobic (all others) conditions at 37°C 
for 2-3 d. As soon as colonies were visible, they were counted and subcultured. Identification was 
performed according to the standard procedures using partially commercial biochemical test kits and 
Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (X2 Bruker MALDI-
TOF Biotyper, Bruker Daltonik GmbH, Bremen, Germany). 
 
 
Determination of the inflamed area 
Based on a standardized methodology (Hujoel et al.  2001)(Nesse et al.  2008), the overall 
(PESA) and inflamed periodontal surface area (PISA) for each individual patient and the instrumented 
periodontal sites per group were calculated. For this purpose, the clinical parameters of periodontal 
pocket depths (PD) and attachment loss (AL) were used. In short, clinical data from the periodontal 
findings sheet were transferred and inserted into an Excel spreadsheet to automatically calculate the 
total epithelialized and inflamed surfaces from the pocket depth, recession and BOP data, based on 
reference data for the anatomy of the individual teeth. 
 
 
Statistical analysis 
Data were entered into a web-based electronic data-capture program (secuTrial®, interActive Systems 
GmbH, Berlin, Germany) by the first author and controlled for entry errors by an external monitor. 
Statistical tests were performed using SPSS 22 for Macintosh (IBM, New York, USA). Data were 
tested for normal distribution (Kolmogorov-Smirnov goodness-of-fit test). To test for differences 
between discrete values, i.e., the prevalence of bacteremia between the groups, the McNemar test 
was performed. Intergroup differences for the number of bacteremia events and the number of colony 
forming units (CFU) per case of bacteremia were tested for differences using the non-parametric 
Wilcoxon test in cases of skewed data distribution. Logistic regression analysis was performed using 
the Spearman coefficient for two continuous variables and Fisher’s exact test to assess the 
significance of the association between the patient’s or clinical parameters (PD, BOP, PESA or PISA, 
gender) and the bacteremia parameters. Furthermore, statistical tests to assess a possible effect of 
sources of variability generally linked to crossover experiments were performed (pkcross, Stata® vs. 
13, StataCorp LP, College Drive, Texas, USA). The level of significance for all tests was set at 5 % (p 
≤ 0.05).  
 
 
Results 
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Twenty patients were enrolled in the study. As the second blood sample of patient No. 7 was 
destroyed during centrifugation, a microbiologic analysis could not be performed. Therefore, the data 
from only 19 patients were used.  
Baseline clinical data (PI, BOP, number of sites with deep probing depths, mean probing depth, mean 
PESA or PISA) for both groups are listed in Table 1. The Wilcoxon test did not reveal any statistically 
significant differences between the groups.  
Table 2 displays the number and species of culturable bacteria in each group. In summary, bacteria 
of oral origin included different Streptococcus spp., Lactobacillus spp. and facultative anaerobic 
bacteria such as Actinomyces spp. but also strictly anaerobic bacteria such as Prevotella spp, 
Clostridium spp. and Fusobacterium spp. 
Bacteremia was found in 11/19 cases in the control group and in 5/19 cases in the test group. After 
the exclusion of cases with typical skin bacteria species, 10/19 (53%) oral-borne bacteremia were 
found in the control group and 2/19 (11%) in the test group. The McNemar test revealed a 
significantly reduced risk for the prevalence of bacteremia of oral origin (p = 0.0133) when PVP-iodine 
was used. When the average number of colony forming units per case of oral-borne bacteremia was 
calculated, 12.2 [1;46] in the control and 3.0 [1;5] in the test group were found. The Wilcoxon test 
showed a significantly smaller number of oral-borne bacteria per case of bacteremia for the test group 
compared to the control group (p = 0.003). Comparing the ratio of aerobic and anaerobic bacteria in 
the two groups, 83.0% turned out to be anaerobic species in the control group, whereas there was no 
anaerobic colony found within the test group (Fig. 2). No patients reported adverse effects after the 
use of PVP-iodine. 
Multiple regression revealed no correlation of the parameters BOP, PI, number of sites ≥ 4 mm, 
PESA or PISA with the prevalence of bacteremia (p-values 0.087, 0.245, 0.214, 0.242, 0.417) or with 
the number of bacteria per case of bacteremia (p-values 0.868, 0.310, 0.493, 0.802 and 0.672, 
respectively). However, there was a correlation of BOP and the number of sites > 4 mm (p = 0.004).  
 
Discussion 
In the present study, we assessed the effect of an intensive rinsing regimen with 10% PVP iodine on 
post-treatment bacteremia after subgingival ultrasonic instrumentation of root surfaces in patients with 
chronic periodontitis. To the best of the authors’ knowledge, this study is the first to assess the 
antiseptic’s effect during subgingival biofilm disruption. After one minute of mouth washing, one 
minute of subgingival rinsing and one minute of subgingival instrumentation of all periodontal pockets 
during PVP-iodine application, we found significantly less bacteria of oral origin in blood samples that 
were taken from the central blood flow three minutes after periodontal instrumentation had begun, 
compared to the same treatment with tap water. A significantly lower incidence of bacteremia was 
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found in the test group, and bacteremia was less pronounced in terms of the number of viable counts 
in the blood samples.  
Bacteremia is a frequent finding after dental treatment (Parahitiyawa et al.  2009). After 
subgingival scaling during non-surgical periodontal therapy, post-treatment bacteremia of oral origin 
occurs in 55-70% of cases (Waghmare et al.  2013, Witzenberger et al.  1982), with a 
72-78% involvement of anaerobes (Brook 2010). Data from the present control group showed a 
comparable incidence of 60% and a contribution of 82% of anaerobic species. A study from the early 
1980s failed to show any effect of subgingival rinsing with PVP-iodine (Witzenberger et al.  
1982) in patients with an average pocket depth of only 3.3 mm. In contrast to the present study, in 
those studies, no antiseptic was applied during instrumentation, i.e., during the mechanical disruption 
of the biofilms. Furthermore, in the cited studies, the microbiological analysis failed to distinguish 
between bacteremia of oral origin and that from the skin or external contamination. In the present 
study, however, in 25% of the samples, bacterial species were found that could not be assigned to 
the oral flora, despite the fact that sampling and processing of the blood were performed under strict 
clinical and laboratory quality standards. Likewise, in a recent study on the use of 7.5% PVP iodine to 
prevent bacteremia after mechanical gingivitis treatment, contamination by non-oral germs was found 
in 40% of the cases (Cherry et al.  2007). It is important to mention that in the latter study, no 
antiseptic was applied during instrumentation. However, the risk for bacteremia was also significantly 
lowered by an odds ratio of 0.189 and was reported to be approximately 80% more effective 
(Cherry et al.  2007). In that study, periodontal pockets accounted for mean probing depths of 
2.2 ± 0.4 mm, which was considerably less than in the present study, with mean probing pocket 
depths of 6.0 mm in both groups. Therefore, a higher rate of bacteremia might be expected. However, 
even subgingival rinsing with water or saline alone, as in our control group, reduces the risk of 
bacteremia, as was previously shown (Witzenberger et al.  1982, Rahn 1993). On the other 
hand, via the use of a special lysis system in the present study that allowed for disruption of 
eukaryote cells and therefore detection of intracellular bacteria, a more exact analysis of bacterial 
species could be performed. Therefore, an incidence of bacteremia of 60 % in our control group 
seemed reasonable.  
The present study was performed using a cross-over split mouth design. Though inter-individual 
variability might be decreased, it is not impossible that the sequence of control and test treatments 
might have affected the outcome. Apart from the fact that both treatment sequences (test – control or 
control – test) were performed in equal ratios, we performed a statistical analysis to assess the 
possible effect of the sequence or period as sources of variability generally linked to cross-over 
experiments (pkcross, Stata® Vs. 13, StataCorp LP, College Drive, Texas, USA). No indication of an 
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effect of sequence or period was found, and no indication for the presence of a carry-over effect was 
found. 
The wound area in both groups was comparable. We aimed to include the assessment of this aspect 
to foreclose any differences in the originally lacerated wound area, which might have affected the 
outcomes. Several attempts have been performed so far to assess the overall size of the inflamed 
area. Assuming a mean periodontal breakdown of one-third of the root length, Jepsen and co-workers 
estimated a total of 20 cm2 of chronically inflamed tissue area (Jepsen 1963). Other studies 
suggested considerably larger wound areas of between 70 and 90 cm2 (Loos 2006). To estimate 
and characterize the total wound size as appropriately as possible, Hujoel et al. used a more 
sophisticated approach to determine the overall area. Therefore, the cone shape of the root surfaces 
and different root anatomies and consequently the enhanced wound area for the initial attachment 
loss were taken into consideration (Hujoel et al.  2001). Based on their publication, evaluation 
tables were published for the calculation of the overall epithelialized (PESA) or inflamed periodontal 
surface area (PISA) for individual patients, which were applied using the documented periodontal 
pocket depths and attachment losses of our patients (Nesse et al.  2008). 
 
Within this study, one single blood sample was taken 3 min after each treatment. Several studies 
collected a blood sample before treatment to ensure a bacteremia-free baseline status. Although such 
an approach might be ideal an ideal pre-condition, it still presents some disadvantages. Therefore, we 
changed this approach, mainly for the following two reasons: First, previous studies with 20 and 60 
patients, respectively, showed the complete absence of oral bacteria in all samples before treatment 
(Cherry et al.  2007, Witzenberger et al.  1982), and subgingival water rinsing did not 
seem to provoke bacteremia (Witzenberger et al.  1982). Second, there is a practical 
disadvantage of additional baseline sampling: either a second puncture of the vein and accordingly 
more discomfort for the patient, or an in-dwelling cannula would have to be placed during several time 
points. The latter, however, allows for bacterial colonization of the device between the samplings and 
therefore distorts the results.  
The time point for sampling was set in accordance with studies investigating the bacterial profile in the 
central blood stream after other dental interventions such as tooth brushing, tooth extraction, pulp 
manipulation and professional cleaning (Brennan et al.  2007, Lockhart et al.  2007). 
These studies showed that the number of viable bacteria in the blood reached their maximum 
between the 2nd and the 3rd post-interventional minutes before declining again during the consecutive 
hour. 
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As an antiseptic agent, PVP-iodine at a concentration of 10% was chosen, as it has been 
recommended as a first-choice solution to reduce oral pathogens by mouth wash or rinsing due to a 
quicker and more pronounced bactericidal effect compared to 0.2% chlorhexidine, the most popular 
antiseptic agent in dentistry (Rahn 1993, Rahn et al.  1995). 
Despite our pursuit of a sophisticated study design, there are still shortcomings of our study. The 
study was conducted as a split-mouth study, which bears the intrinsic risk of the test treatment 
confounding the results of the control site and vice versa. However, choosing this methodological 
approach, we could benefit from advantages such as more adequately equilibrated environmental 
factors including smoking, general health and stress. In fact, our baseline data showed no significant 
differences. With a wash–out period of at least 2 weeks, an ample time span was set to avoid 
reciprocal treatment effects as much as possible. Furthermore, according to the study protocol, no 
proper cleaning of the pocket areas could be performed, but we aimed for a quick instrumentation to 
disrupt as much biofilm as quickly as possible. Therefore, a sharp rise in the prevalence and severity 
of bacteremia was evoked. In doing so, blood sampling could be performed at well-defined time 
points at the previously discussed maximum peak of bacteremia. However, proper scaling and root 
planing were performed after blood sampling and not as part of the study treatment.  
By culturing bacteria from the blood samples, only viable bacteria were screened. Therefore, we 
could not identify bacterial components and bacteria that were already eliminated by the immune 
system of the healthy subjects, bacteria that transformed into a non-cultivable state despite remaining 
vital, or bacteria that did not survive until being processed. In addition, the analysis is highly 
technique-sensitive, as some bacteria might not survive the culturing process or at least would not 
form colonies (Wardle 1997). With highly specific tests based on genetic analysis methods (FISH 
etc.), it would have been possible to expand the search for selected bacteria. However, as there were 
no specific strains or bacteria of interest, we refrained from doing so in the present study.  
The detected bacteria represent a variety of species. The spectrum included anaerobic Gram-
negative and –positive rods, anaerobic Gram-positive cocci, as well as typical periodontal marker 
bacteria such as Fusobacterium spp., Porphyromonas gingivalis, Fusobacterium nucleatum and 
Prevotella intermedia. Accordingly, the spectrum covers a wide range of different germs and is in 
accordance with the findings of other studies (Cherry et al.  2007, Forner et al.  2006, 
Lockhart et al.  2008, Witzenberger et al.  1982), specifically Streptococci viridans and 
Aggregatibacter spp., which are frequently involved in endocarditis lesions or are associated with 
inflammation of prosthetic heart valves, shunts or catheters (Zimmerli et al.  2004).  
In the context of the present study, however, it is important to state that transient bacteremia might 
occur several times a day, caused by tooth brushing or even chewing (Forner et al.  2006, 
Lockhart et al.  2008). In healthy patients, their acute impact on health is negligible. However, it 
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was shown that bacteremia is followed by an inflammation of the endothelium, which results in 
hampered endothelial function 24 h after periodontal treatment in healthy patients (Tonetti 2009).  
High-risk patients, as defined by the American Heart Association (Wilson et al.  2008), or 
patients in intensive care (such as mechanically ventilated patients) face a strongly enhanced risk of 
developing infections caused by the proliferation of oral-borne bacteria (Jones et al.  2010). 
These complications, namely endocarditis and infections of endoprostheses, stand out due to 
significant treatment costs and high morbidity due to invasive surgery and mortality (Fink et al.  
2008). According to the guidelines, these patients are encouraged to take broad-spectrum 
antibiotics one hour before each dental consultation to avoid the circulation of bacteria that may be 
displaced by any action that leads to a bleeding in the oral cavity. Against the background of growing 
antimicrobial resistance of anaerobic bacteria (Brook 2010), these patients might benefit from any 
effective measure to additionally lower the bacterial load in the central blood stream and accordingly 
should be pretreated before and during instrumentation with a rinse of 10% PVP-iodine.  
 
Conclusion  
Rinsing with 10% PVP-iodine significantly reduces the risk for post-treatment bacteremia during non-
surgical periodontal therapy. Rinsing therefore seems to be recommendable, especially in patients 
with a high risk for endocarditis or infection of endo-prostheses. As the incidence of bacteremia 
seems to not be completely eliminable, however, preventive antibiotic treatment should not be omitted 
in high-risk patients. 
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Figure 1 
Flow-chart of the study protocol 
 
 
 
 
Figure 2 
Incidence of bacteremia and proportion of aerobe and anaerobe colonies per group. 
 
 
Tables 
 
 
 
Table 1  
Baseline data for both groups (means ± standard deviations) 
 
 
 
 Control Test   P 
Age [y]                      52.7±11.9   
Gender [m/f]                         80/20   
PI [%] 58.7±31.1 53.4±31.4 0.884 
BOP [%] 54.0±25.3 51.4±26.8 0.794 
PPD > 4 mm [n] 19.8±13.9 20.7±13.3 0.841 
Mean PPD [mm] 6.0±0.8 6.0±1.7 0.897 
PESA [mm2] 917.8±422.9 1009.4±485 0.562 
PISA [mm2] 504.0±375.9 665.5±474.1 0.279 
 
  
Table 2  
Presentation of the individually identified bacteria and the counts of viable bacteria in the respective 
blood samples (in brackets). 
 
 
Patient 
number 
Control (water) Test (PVP-iodine) 
Non-oral Oral Non-oral Oral 
1 
 
 Parvimonas micra (3) Proprionibacterium 
acnes (2) 
Staphylococcus 
hominis (1) 
R. dentocariosa (2) 
Streptococcus viridans 
(3) 
2 
 
S. hominis (2) P. micra (1) 
Streptococcus viridans 
(3) 
P. acnes (1) - 
3 
 
- - - - 
4 
 
- P. micra (2) 
Streptococcus 
constellatus (2) 
- Streptococcus 
mitis/oralis (1) 
5 
 
- - - - 
6 
 
- - - - 
7 
(excluded) 
 
(Sample damaged) (Sample damaged) - - 
8 
 
- - - - 
9 
 
Dermatobacter 
hominis (1) 
Veillonella spp. (1) 
P. micra (4) 
Prevotella intermedia (4) 
S. constellatus (2) 
Atopobium rimae (2) 
- Anaerobe Gram-rods 
(8) 
- Anaerobe Gram+ rods 
(4) 
- Anaerobe Gram+ 
coccus (1) 
- - 
10 
 
- - - - 
11 
 
- - - - 
12 
 
- Streptococcus 
anginosus (1) 
- - 
13 - - - - 
14 
 
P. acnes (2) P. micra (1) 
Fusobacterium spp. (4) 
P. acnes (1) 
Corynebacterium 
accolens (2) 
- 
15 
 
- S. anginosus (11) 
Aggregatiabacter 
aphrophilus (6) 
Fusobacterium spp. (8) 
P. micra (8) 
- Anaerobe Gram+ rods 
(3) 
- Anaerobe Gram+ cocci 
(6) 
- Anaerobe Gram- rods 
(4) 
- - 
16 
 
- - - - 
17 
 
P. acnes (2) 
S. hominis (2) 
 
- - - 
18 P. acnes (1) 
Propriobacterium 
avidum (1) 
S. mitis (2) P. acnes (1) 
 
- 
 
19 
 
- Anaerobe Gram- rods 
(4) 
Actinomyces spp. (14) 
A. meyeri (4) 
P. intermedia (2) 
- - 
20 - Clostridium spp. (4) 
Fusobacterium 
nucleatum (1) 
Porphyromonas 
gingivalis (1) 
Lactobacillus spp. (1) 
- - 
 
